Adamis Pharmaceuticals Corp

NASDAQ:ADMP  
0.99
-0.04 (-3.43%)
4:51:10 PM EDT: $0.99 0.00 (0.31%)
Products

Adamis Pharmaceuticals Resubmits Zimhi New Drug Application To FDA For The Treatment Of Opioid Overdose

Published: 05/17/2021 11:43 GMT
Adamis Pharmaceuticals Corp (ADMP) - Adamis Pharmaceuticals Resubmits Zimhi New Drug Application to FDA for the Treatment of Opioid Overdose.